Get the Stockscreener App
245.73
1.22%
-3.03
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $245.73, with a volume of 583.36K.
It is down -1.22% in the last 24 hours and up +6.62% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$248.76
Open:
$249.4
24h Volume:
583.36K
Relative Volume:
0.78
Market Cap:
$20.73B
Revenue:
$12.71B
Net Income/Loss:
$435.50M
P/E Ratio:
47.71
EPS:
5.15
Net Cash Flow:
$843.20M
1W Performance:
-0.78%
1M Performance:
+6.62%
6M Performance:
+1.38%
1Y Performance:
+19.20%
1-Day Range:
$245.45
$249.69
1-Week Range:
$243.34
$252.68
52-Week Range:
$191.97
$258.59
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
245.73 | 20.73B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp to Webcast Its Annual Meeting of Shareholders May 15 - The Malaysian Reserve
LabCorp Holdings Inc. (LH) Files Form 8-K with SEC - GuruFocus
Labcorp Holdings to Webcast Annual Shareholder Meeting - TipRanks
Justices' Labcorp Questions Explore Class Cert. Tensions - Law360
Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72 - Yahoo Finance
Most Shareholders Will Probably Agree With Labcorp Holdings Inc.'s (NYSE:LH) CEO Compensation - simplywall.st
Labcorp Holdings' (NYSE:LH) Earnings May Just Be The Starting Point - Yahoo Finance
How A Labcorp Ruling Could Affect Wage Class Actions - Law360
Labcorp Holdings (LH) Price Target Raised by Piper Sandler | LH Stock News - GuruFocus
Analyst Expectations For Labcorp Hldgs's Future - Benzinga
Piper Sandler Adjusts Labcorp Holdings Price Target to $280 From $260, Maintains Neutral Rating - marketscreener.com
Labcorp case at Supreme Court could set precedent for class-action lawsuits - The Business Journals
Labcorp (LH) Receives Price Target Boost from Piper Sandler | LH Stock News - GuruFocus
Labcorp Holdings Inc, BioReference Health, OPKO Health, Inc. - Olean Times Herald
Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight - GuruFocus
Labcorp: Q1 Earnings Snapshot - Bluefield Daily Telegraph
Why Labcorp (LH) is a Top Value Stock for the Long-Term - Yahoo Finance
BlackRock, Inc. Reduces Stake in Labcorp Holdings Inc. - GuruFocus
Baird Adjusts Labcorp Holdings' Price Target to $267 From $253 - marketscreener.com
Labcorp (LH) Price Target Raised by Baird Following Q1 Results | - GuruFocus
Labcorp’s Stock Price Target Raised on Strong Q1 (NYSE: LH) - AskTraders.com
Labcorp Holdings First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Barclays Adjusts Labcorp (LH) Price Target, Maintains Equal Weig - GuruFocus
Barclays Adjusts Labcorp (LH) Price Target, Maintains Equal Weight Rating | LH Stock News - GuruFocus
Labcorp targets 10% EPS growth with new diagnostics and acquisitions strategy - MSN
Earnings call transcript: LabCorp Q1 2025 shows revenue growth but misses forecast - Investing.com
Labcorp beats earnings estimates, stock jumps 5% as acquisitions drive growth - The Business Journals
Labcorp Q1 2025 slides: Revenue up 5.3%, maintains strong 2025 outlook By Investing.com - Investing.com Canada
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Outpaces Expectations With Strong Diagnostic Demand - Finimize
Our Labcorp Price Target as Latest Results Surprise - TheStreet Pro
Labcorp (LH) Q1 Earnings Miss Estimates, Revenue Guidance Reaffi - GuruFocus
Labcorp (LH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Labcorp (LH) Revises 2025 Revenue Outlook with Strong Growth Pro - GuruFocus
Labcorp Q1 Earnings Surpass Estimates, Revenues Miss, Stock Gains - Nasdaq
Labcorp Announces 2025 First Quarter Results - GuruFocus
Labcorp Holdings Inc Reports Q1 2025 Earnings: EPS of $2.52 and Revenue of $3.35 Billion, Both Below Estimates - GuruFocus
Labcorp (LH) Beats Q1 Earnings Estimates - Yahoo Finance
Labcorp (LH) Reports First Quarter 2025 Financial Results | LH S - GuruFocus
Labcorp Misses Revenue Expectations but Reports EPS Growth in Q1 2025News and Statistics - IndexBox
Labcorp beats quarterly profit estimate on diagnostic test demand - Reuters
Labcorp Holdings Inc. Q1 Profit Decreases, But Beats Estimates - Nasdaq
Labcorp (NYSE:LH) Reports Sales Below Analyst Estimates In Q1 Earnings - Yahoo Finance
Labcorp Announces 2025 First Quarter Results and Updates Full-Year Guidance - TradingView
Earnings Flash (LH) Labcorp Holdings Posts Q1 Revenue $3.35B, vs. FactSet Est of $3.40B - marketscreener.com
Earnings Preview: Laboratory Corp - Benzinga
Labcorp (LH) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.94%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):